Both in Pharmaceuticals
Altimmune vs Assembly Biosciences
Over the past year ALT returned −43.6% and ASMB returned −36.8%; their daily moves had a correlation of 0.23.
ALT −43.6% ASMB −36.8%Growth of $1, one year, split-adjusted
| Metric | ALT | ASMB |
|---|---|---|
| Price | $2.12 | $19.87 |
| Market cap | $412.4M | $404.6M |
| Today | +3.92% | −0.25% |
| 1 month | −20.6% | −10.4% |
| 6 months | −35.0% | −36.6% |
| Year to date | −41.3% | −41.6% |
| 1 year | −46.5% | −36.3% |
| Revenue growth (YoY) | −100.0% | +38.9% |
| Gross margin | — | 100.0% |
| Net margin | — | −28.8% |
| P/E (TTM) | — | — |
| Price / sales | 13,302.5× | 5.4× |
| Net cash | $291.5M | $320.4M |
| Dividend yield | — | — |
| Volatility (60d) | 47.8% | 63.6% |
| Short % of float | 22.2% | 28.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).